Vaccines are the most important line of defense to protect public health and the spread of disease during influenza pandemics. Yet the 2009 experience with pandemic H1N1 influenza showed that manufacturers, wealthy and poor governments were completely unprepared for the demands that global demand for vaccine production and distribution might impose. This chapter analyzes the failures of the system in 2009-10 with the aim of facilitating greater preparedness for future influenza pandemics
The public health response to the threat of pandemic influenza A (H1N1) virus during the 2009–2010 i...
The recent experience in the United States with a shortage in available doses of flu vaccine demonst...
In this article, I argue that the Pandemic Influenza Preparedness (PIP) Framework is unlikely to hav...
In the wake of the 2004 shortage, the current system of influenza vaccine development, supply, and d...
Vaccines are hugely important tools in minimising the effect pandemic influenza could have on a popu...
Recent years’ enzootic spread of highly pathogenic H5N1 virus among poultry and the many lethal zoon...
Influenza disease epidemics occur seasonally in the United States and cause significant morbidity an...
AbstractAs A(H1N1) influenza enters the post-pandemic phase, health authorities around the world are...
Influenza viruses circulate worldwide causing annual epidemics that have a substantial impact on pub...
Background:National seasonal influenza programs have been recommended as a foundation for pandemic p...
AbstractIt is predicted that in case of an influenza pandemic, there will be a significant gap betwe...
Abstract Background: During the 2009 H1N1 pandemic, the global health community sought to make vacci...
A novel strain of Influenza A (H1N1) spread rapidly through Mexico in April 2009 and now spans the g...
Dr. Russell explains how such matters as high \u27costs of regulation, lack of an effective plan for...
Examines capacities and challenges in preparing for and responding to an H1N1 flu pandemic, includin...
The public health response to the threat of pandemic influenza A (H1N1) virus during the 2009–2010 i...
The recent experience in the United States with a shortage in available doses of flu vaccine demonst...
In this article, I argue that the Pandemic Influenza Preparedness (PIP) Framework is unlikely to hav...
In the wake of the 2004 shortage, the current system of influenza vaccine development, supply, and d...
Vaccines are hugely important tools in minimising the effect pandemic influenza could have on a popu...
Recent years’ enzootic spread of highly pathogenic H5N1 virus among poultry and the many lethal zoon...
Influenza disease epidemics occur seasonally in the United States and cause significant morbidity an...
AbstractAs A(H1N1) influenza enters the post-pandemic phase, health authorities around the world are...
Influenza viruses circulate worldwide causing annual epidemics that have a substantial impact on pub...
Background:National seasonal influenza programs have been recommended as a foundation for pandemic p...
AbstractIt is predicted that in case of an influenza pandemic, there will be a significant gap betwe...
Abstract Background: During the 2009 H1N1 pandemic, the global health community sought to make vacci...
A novel strain of Influenza A (H1N1) spread rapidly through Mexico in April 2009 and now spans the g...
Dr. Russell explains how such matters as high \u27costs of regulation, lack of an effective plan for...
Examines capacities and challenges in preparing for and responding to an H1N1 flu pandemic, includin...
The public health response to the threat of pandemic influenza A (H1N1) virus during the 2009–2010 i...
The recent experience in the United States with a shortage in available doses of flu vaccine demonst...
In this article, I argue that the Pandemic Influenza Preparedness (PIP) Framework is unlikely to hav...